Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques

被引:24
作者
Haga, Yoshimi [1 ]
Ueda, Koji [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Precis Med Ctr, Canc Prote Grp, Tokyo 1358550, Japan
关键词
Biomarker; Cancer; Carbohydrate epitope; Glycosylation; Mass spectrometry; PROSTATE-SPECIFIC ANTIGEN; MOBILITY-MASS SPECTROMETRY; EPITHELIAL OVARIAN-CANCER; GROWTH-FACTOR RECEPTOR; FUCOSYL-TRANSFERASE; 8; SIALOSYL-TN-ANTIGEN; BREAST-CANCER; ALPHA-FETOPROTEIN; IMMUNOGLOBULIN-G; TUMOR-MARKERS;
D O I
10.1007/s10719-022-10043-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite significant worldwide investment in research, cancer remains one of the most common cause of death in the world. Early detection and reliable diagnosis are the keys to effectively treating cancer and improving the long-term survival of cancer patients. Therefore, there is an urgent need to develop a single, non-invasive biomarker with high sensitivity and specificity. Aberrant glycosylation is well defined as a hallmark of cancer and represents a promising source of potential biomarkers. Tumor-associated carbohydrate epitopes have long been detected by using monoclonal antibodies and lectins. Recent advances in analytical technologies allow us to analyze cancer-specific glycoforms on a target protein in a variety of clinical samples. A number of glycan analysis techniques, such as lectin-based detection methods and mass spectrometry combined with various types of chromatography, have been developed to establish novel glycoform-specific cancer biomarkers. Several glycan-based cancer biomarkers are already in clinical use. The aim of this review is to outline the role of glycan as a cancer biomarker and to summarize the current status and the potential for contribution of the serum glycoproteome to cancer diagnostics, monitoring, and prognostics.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 138 条
[1]   Recent advances in glycoinformatic platforms for glycomics and glycoproteomics [J].
Abrahams, Jodie L. ;
Taherzadeh, Ghazaleh ;
Jarvas, Gabor ;
Guttman, Andras ;
Zhou, Yaoqi ;
Campbell, Matthew P. .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2020, 62 :56-69
[2]   Glycans as cancer biomarkers [J].
Adamczyk, Barbara ;
Tharmalingam, Tharmala ;
Rudd, Pauline M. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (09) :1347-1353
[3]   The promise of protein glycosylation for personalised medicine [J].
Almeida, Andreia ;
Kolarich, Daniel .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (08) :1583-1595
[4]   Lectins: tools for the molecular understanding of the glycocode [J].
Ambrosi, M ;
Cameron, NR ;
Davis, BG .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (09) :1593-1608
[5]  
ANDRENSANDBERG A, 1989, ACTA CHIR SCAND, P75
[6]   Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review [J].
Ballehaninna U.K. ;
Chamberlain R.S. .
Indian Journal of Surgical Oncology, 2011, 2 (2) :88-100
[7]   Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer [J].
Barrabes, Silvia ;
Llop, Esther ;
Ferrer-Batalle, Montserrat ;
Ramirez, Manel ;
Aleixandre, Rosa N. ;
Perry, Antoinette S. ;
de Llorens, Rafael ;
Peracaula, Rosa .
CLINICA CHIMICA ACTA, 2017, 470 :97-102
[8]   MICROHETEROGENEITY OF ALPHA-FETOPROTEIN IN PATIENT SERUM AS DEMONSTRATED BY LECTIN AFFINO-ELECTROPHORESIS [J].
BREBOROWICZ, J ;
MACKIEWICZ, A ;
BREBOROWICZ, D .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 14 (01) :15-20
[9]  
BREMER EG, 1986, J BIOL CHEM, V261, P2434
[10]  
Brockhausen I., Essentials of Glycobiology, P113